Navigation Links
ESC reaffirms advice on cardiovascular risks associated with long-haul flights
Date:2/24/2009

Following a review by The Lancet of the medical issues associated with commercial air travel, the European Society of Cardiology has reaffirmed its advice about the risks of venous thromboembolism (VTE), whose risk, according to The Lancet, is increased "up to four-fold" by long-haul flight.

Dr Steen Kristensen, Vice-president of the ESC, says: "Long distance flying is associated with an increase in deep venous thrombosis, which in some cases may lead to clotting of the lungs. People who are immobile, pregnant, taking contraceptive pills or have had venous thrombosis in the past are particularly at risk. To minimise the risk it is important to drink plenty of non-alcoholic fluid and to walk (exercise) before and during the flight. The use of compression stockings is for some travelers an important way of preventing deep venous thrombosis."

Studies cited by The Lancet suggest that the risk of VTE increases when flight duration exceeds four hours. This raised risk is related to immobility, dehydration, and reduced oxygen in the cabin, as well as to individual risk factors such as obesity, recent surgery and predispositions to thrombosis (thrombophilias).

On the subject of risk Professor Kurt Huber, ESC spokesperson on Thrombosis, writes: "Prone to thromboembolic risk are those with a history of venous thrombosis or pulmonary embolism, but also those with a history of atherothrombotic diseases (for example, myocardial infarction or stroke) and those with heart failure, atrial fibrillation, and physical immobilisation." Professor Huber adds that even healthy people may develop thrombotic problems on a long-distance flight, notably pregnant women, women taking oral contraceptives (especially if they smoke) and the elderly. Those with concerns, he adds, should ask their doctor about their individual risk and the applicability of preventive measures, including medication.

With reference to the more serious cardiovascular complications of long-haul flight, Professor Panos E Vardas, president elect of the European Heart Rhythm Association (EHRA), commenting on behalf of the ESC, notes that loss of consciousness can occur during flight, for either benign or malignant reasons. The most common causes of benign episodes, explains Professor Vardas, include vasovagal syncope (fainting), whose most frequent cause is low blood pressure, especially in elderly patients who are taking certain medications.

Professor Vardas continues: "In the case of malignant arrhythmias, the loss of consciousness is most commonly attributed to ventricular tachycardia or ventricular fibrillation. Less dangerous cardiac arrhythmias which could also lead to loss of consciousness include paroxysmal atrial fibrillation, atrial flutter or paroxysmal atrial tachycardias.

The best course of action in the case of loss of consciousness is the currently recommended practice of ensuring that the patient remains in a lying down position, with the legs elevated. Simultaneously, if the syncopal episode lasts more than 30-40 seconds and if the automatic device advises defibrillation, the defibrillator should be activated.

Major European airlines already carry defibrillators and train their personnel to use them under the guidance of medical assistance on-ground. Hopefully, in the future,the use of automatic external defibrillators and the training of personnel will be extended to all commercial flights."

The European Society of Cardiology is currently preparing a policy statement on the safety of commercial air travel in cardiac patients.


'/>"/>

Contact: ESC Press Office
press@escardio.org
33-049-294-8627
European Society of Cardiology
Source:Eurekalert

Related medicine news :

1. China Sky One Medical, Inc. Reaffirms Guidance for 2008 Revenue and Net Income and Provides Business Update
2. The Ensign Group, Inc. Reports Third Quarter 2008 Earnings; Reaffirms 2008 Guidance
3. HealthSouth Reaffirms Business Fundamentals and Full Year 2008 Guidance
4. AMDL Reaffirms 2008 Guidance and Provides Additional Information
5. Grocery Manufacturers Association: FDA Once Again Reaffirms Safety of Bisphenol A (BPA) for All Consumers
6. Lotus Pharmaceuticals, Inc. Reaffirms its Confidence in Meeting its Make Good Target for Fiscal Year 2008
7. Biopure Reaffirms Strategy Following Recent NIH/FDA Workshop
8. Gentiva(R) Health Services Announces First Quarter 2008 Results and Reaffirms Financial Outlook
9. Grocery Manufacturers Association: Canadian Risk Assessment Reaffirms Safety of Bisphenol A (BPA) for Adults and Children
10. Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
11. Omnicell Announces Common Stock Repurchase Program; Reaffirms Earnings Forecast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 top five ... art competition. Selected from 15 submissions from around the nation, the top five finalists ... iaedp Symposium, March 22 – 26 in Las Vegas. , This year, the competition ...
(Date:2/24/2017)... Fair Lawn, NJ (PRWEB) , ... February 24, ... ... with robust marketing services, which specializes in thought leadership , media ... email marketing campaigns and services that will be powered through Act-On, an intuitive ...
(Date:2/23/2017)... ... 2017 , ... Thinksport, the most award-winning sunscreen on the ... Marin. For the second year in a row, cyclists will stay protected from ... thrilled to provide our safe, non-toxic sunscreen to over 2,000 cycling enthusiasts again ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Lymphoma Research Foundation ... research and serving the lymphoma community through a comprehensive series of education programs, ... Club in Miami Beach to host its Swirl: Miami Wine Tasting Event on ...
(Date:2/23/2017)... ... 2017 , ... Los Angeles-based weight loss surgeon Michael Feiz, M.D., F.AC.S. will ... to Hot,” which will begin airing on February 24, 2017. The show chronicles the ... 2012 reality television series, “Here Comes Honey Boo Boo.” The earlier series from TLC ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017  In conjunction with DURECT Corporation,s (Nasdaq: ... release, you are invited to listen to a conference ... on Tuesday, March 14, 2017 at 4:30 pm Eastern ... audio webcast of the presentation will be available by ... "Investor Relations."  If you are unable to participate during ...
(Date:2/24/2017)... , Feb. 24, 2017 Juan ... & Associates PC , a boutique securities firm headquartered ... York City , announces that a class action ... Massachusetts  against Inotek Pharmaceuticals Corporation (NASDAQ: ... the Company,s securities between July 23, 2015 and December 30, ...
(Date:2/24/2017)... NEW YORK , Feb. 23, 2017 Report ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... estimates and forecasts are provided for the period 2015 through ... markets. Market data and analytics are derived from primary and ...
Breaking Medicine Technology: